Abstract
The autonomic nervous system functions at a delicate balance to sustain a relatively constant internal milieu despite exposure to ever changing external and internal environments. For example, changes in temperature and altitude evoke compensatory autonomic responses to maintain body temperature and respiratory function. Likewise, sudden standing can lower arterial pressure, resulting in activation of baroreceptor reflex arcs to sustain cardiovascular function. In addition to alterations in the external environment, disease and injury can necessitate compensatory autonomic responses. However, in pathophysiological states, the autonomic nervous system may be severely compromised and unable to function in the rapid restoration of homeostasis.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Krieger, D.T. 1982. Endorphins and enkephalins. Disease-a-Month. Chicago: Year Book Medical Publisher, Inc., 1–53.
Watson, S.J. and Barchas, J.D. 1979. Anatomy of the endogenous opioid peptides and related substances: the enkephalins, beta-endorphin, beta-lipotropin and ACTH. In Beer, R.F. and Bassett, E.G.(eds.): Mechanisms of Pain and Analgesic Compounds. New York, Raven, 227–238.
Hokfelt, T., Elde, R., Johansson, O., Terenius, L. and Stein, L. 1977. The distribution of enkephalin-immunoreactive cell bodies in the rat central nervous system. Neurosci. Lett. 5, 25–31.
Puig, M.M., Gascon, P., Craviso, G.L. and Musacchio, J.M. 1977. Endogenous opiate receptor ligand: electrically induced release in the guinea pig ileum. Science 195, 419–420.
Diguilio, A.M., Yang, H.Y.T., Lutold, B., Fratta, W., Hong J. and Costa, E. 1978. Characterization of enkephalin-like material extracted from sympathetic ganglia. Neuropharmacology 17, 989–992.
Schultzburg, M., Hokfelt, T., Lundberg, J., Terenius, L., Elfirm, L.G., and Elde, R. 1978. Enkephalin-like immuno-reactivity in nerve terminals in sympathetic ganglia and adrenal medulla and in adrenal medullary cells. Acta Physiol. Scand 103, 475–477.
Viveros, O.H., Diliberto, E.J., Hazum, E. and Chang, K.J. 1979. Opiate-like materials in the adrenal medulla: evidence for storage and secretion with catecholamines. Mol. Pharm. 16, 1101–1108.
Guillemin, R., Vargo,T., Rossier, J., Minick, S., Ling, N. Rivier, C, Vale, W. and Bloom, F. 1977. Beta-endorphin and adrenocorticotropin are secreted concomitantly by the pituitary gland. Science 197, 1367–1369.
Holaday, J.W. and Tortella, F.C. 1984. Multiple opioid receptors: possible physiological functions of mu and delta binding sites in vivo. In Muller, E.E. and Genazzani, A.R. (eds.): Central and Peripheral Endorphins: Basic and Clinical Aspects. New York: Raven, 237–250.
Pfeiffer, A. and Herz, A. 1982. Discrimination of three opiate receptor binding sites with the use of a computerized curve fitting technique. Mol. Pharmacol. 21, 266–271.
Holaday, J.W., Long, J.B. and Tortella, F.C. Evidence for kappa, mu and delta opioid binding site interactions in vivo. Fed. Proc. In press.
Gordon, C.J., Rezvani, A.H. and Heath, J.E. 1984. Role of beta-endorphin in the control of body temperature in the rabbit. Neurosci. Biobehav. Rev. 8, 73–82.
Clark. W.G. 1979. Influence of opioids on central thermoregulatory mechanisms. Pharmacol. Biochem & Behav. 10, 609–613.
Holaday, J.W. and Loh, H.H. 1981. Neurobiology of beta-endorphin and related peptides. In Li, C.H.(ed.): Hormonal Proteins and Peptides: Beta-endorphin. New York: Academic Press, 204–291.
Deeter, W.T. and Mueller, G.P. 1981. Differential effects of warm and cold ambient temperature on blood levels of beta-endorphin and prolactin in the rat. Proc. Soc. Exp. Biol. Med. 168, 369–372.
Holaday, J.W., Wei, E.T., Loh, H.H. and Li, C.H. 1978. Endorphins may function in heat adaptation. Proc. Natl. Acad. Sci. 75, 2923–2927.
Holaday, J.W. and Faden, A.I. 1980. Naloxone acts at central opiate receptors to reverse hypotension, hypothermia, and hypoventilation in spinal shock. Brain Res. 189, 295–299.
Florez, J. and Mediavilla, A, 1977. Respiratory and cardiovascular effects of met-enkephalin applied to the ventral surface of the brain stem. Brain Res. 183, 585–590.
Sapru, H.N. and Krieger, A.J. 1979. Cardiovascular and respiratory effects of (D-Met -Pro -enkephalinamide in the decerebrate rat. Fed. Proc. 38, 681.
Moss, I.R. and Friedman, E. 1978. Beta-endorphin effects on respiratory regulation. Life Sci. 23, 1271–1276.
Sapru, H.N., Willette, R.N. and Krieger, A.J. 1981. Stimulation of pulmonary J receptors by an enkephalin analog. J. Pharmacol. Exp. Ther. 217, 228–234.
Holaday, J.W. 1983. Cardiovascular effects of endogenous opiate systems. Ann Rev. Pharmacol. Toxicol. 23, 541–594.
Ward, S.J. and Holaday, J.W. 1982. Relative involvement of mu and delta opioid mechanisms in morphine-induced depression of respiration in rats. Soc. Neurosci. Abstr. 8, 388.
Lawson, E.E., Waldrop, T.G. and Eldridge, F.L. 1979. Naloxone enhances respiratory output in cats. J. App. Physiol.: Respir. Environ. Exercise Physiol. 47, 1105–1111.
Isom, G.E. and Elshowihy, R.M. 1982. Naloxone-induced enhancement of carbon dioxide stimulated respiration.
Chernick, V., Madansky, D.L. and Lawson, E.E. 1980. Naloxone decreases the duration of primary apnea with neonatal asphyxia. Pediatr. Res. 14, 357–359.
Moss, I.R. and Scarpelli, E.M. 1979. Generation and regulation of breathing in utero: fetal C02 response test. J. App. Physiol 47, 527–531.
Malcolm, D.S. and Holaday, J.W. Opioid peptides and their antagonists: a role in respiratory function. Seminars in Respir. Med. In press.
Kiang, J.G. and Wei, E.T. 1984. Peripheral opioid receptors influencing heart rate in rats: evidence for endogenous tolerance. Reg. Peptides 8, 297–303.
Lemaire, I., Tseng, R. and Lemaire, S. 1978. Systemic administration of beta-endorphin: potent hypotensive effect involving a serotonergic pathway. Proc. Natl. Acad. Sci. 75, 6240–6242.
Sander, G., Giles, T., Kastin, A., et al. Leucine-enkephalin: reversal of intrinsic cardiovascular stimulation by pentobarbital. Eur. J. Pharmacol. In press.
Feldberg, W. and Wei. E. 1978. Central cardiovascular effects of enkephalins and c-fragment of lipotropin. J. Physio. 280, 18P.
Harder, D.R. and Madden, J.A. 1984. Cellular mechanisms of opiate receptor stimulation in cat middle cerebral artery. Eur. J. Pharmacol. 102, 411–416.
Holaday, J.W. and Faden, A.I. 1978. Naloxone reversal of endotoxin hypotension suggests role of endorphins in shock. Nature 275, 450–451.
Faden, A.I. and Holaday, J.W. 1980. Naloxone treatment of endotoxin shock: stereospecificity of physiologic and pharmacologic effects in the rat. J. Pharmacol. Exp. Ther. 212, 441–447.
Reynolds, D.G., Gurll, N.J., Vargish, T., et al, 1980. Blockade of opiate receptors with naloxone improves survival and cardiac performance in canine endotoxic shock. Circ. Shock 7, 39–48.
Holaday, J.W., D’Amato, R.J., Ruvio, B.A., et al. 1983. Adrenalectomy blocks pressor responses to naloxone in endotoxic shock: evidence for sympatho-medullary involvement. Cir. Shock 11, 201–210.
Holaday, J.W., Pasternak, G.W. D’Amato, R.J., Ruvio, B.A. and Faden, A.I. 1983. Naloxazone lacks therapeutic effects in endotoxic shock yet blocks the effects of naloxone. Eur. J. Pharmacol. 89, 293–296.
D’Amato, R.J. and Holaday, J.W. 1984. Multiple opiate receptors in endotoxic shock: evidence for delta involvement and mu-delta interactions in vivo. Proc. Nat’l Acad. Sci. 81, 2898–2901.
Long, J.B., Ruvio, B.A., Glatt, C.E. and Holaday, J.W. ICI 174864, a putative delta opioid antagonist, reverses endotoxemic hypotension: pretreatment with dynorphin 1–13, a K agonist, blocks this action. Neuropeptides. In press.
Koyama, S., Santiesteban, H.L., Ammons, W.S. and Manning, J.W. 1983. The effects of naloxone on the peripheral sympathetics in cat endotoxin shock. Circ. Shock 10, 7–13.
Long, J.B., Lake, C.R., Reid, A., et al. 1983. Effects of naloxone and TRH on plasma catecholamines and arterial pressure in normal and endotoxemic rats. Soc. Neurosci. Abstr. 9, 107.
Paciorek, P.M. and Todd, M.H. 1982. Comparison of the cardiovascular effects of meptazinol and naloxone following anaphylactic shock in anesthetized rats. Br. J. Pharmacol. 75, 128P.
Amir S. 1982. Opiate antagonists improve survival in anaphylactic shock. Eur. J. Pharmacol. 80, 161–162.
Amir. S. 1983. Antianaphylactic effect of naloxone in mice is mediated by increased central sympathetic outflow to sympathetic nerve endings and adrenal medulla. Brain Res. 274, 180–183.
Lux, W.E., Feuerstein, G. and Faden, A.I. 1983. Alteration of leukotriene D4 hypotension by thyrotropin releasing hormone. Nature 302, 822–824.
Faden, A.I. and Holaday, J.W. 1979. Opiate antagonists: a role in the treatment of hypovolemic shock. Science 205, 317–318.
Vargish, T., Reynolds, D.G., Gurll, N.J., et al. 1980. Naloxone reversal of hypovolemic shock in dogs. Circ. Shock 7, 31–38.
Curtis, M.T. and Lefer, A.M. 1982. Beneficial action of a new opiate antagonist (WIN 44, 441–3) in hemorrhagic shock. Eur. J. Pharmacol. 78, 307–313.
Feuerstein, G., Faden, A.I. and Krumins, S.A. 1984. Alteration in opiate receptors binding after hemorrhagic shock. Eur. J. Pharmacol. 100, 245–246.
Lechner, R.B., Gurll, N.J. and Reynolds, D.G. Intracoronary naloxone in hemorrhagic shock: dose-dependent, stereospecific effects. Am. J. Physiol. In press.
Holaday, J.W. and Faden, A.I. 1980. Naloxone acts at central opiate receptors to reverse hypotension, hypothermia and hypoventilation in spinal shock. Brain Res. 189, 295–299.
Faden, A.I., Jacobs, T.P. and Holaday, J.W. 1980. Endorphin-parasympathetic interaction in spinal shock. J. Autonomic Nerv. System 2, 295–304.
Tiengo, M. 1980. Naloxone in irreversible shock. Lancet, i, 690.
Peters, W.P., Johnson, M.W., Friedman, P.A. and Mitch, W.E. 1981. Pressor effect of naloxone in septic shock. Lancet i, 529–532.
Gurll, N.J. 1983. Naloxone in endotoxic shock: experimental models and clinical perspective. In Reichard, S. and Reynolds, D. (eds.): Advances in Shock Research, Vol. 10. New York: Alan R. Liss, 63–72.
Belenky, G.L. and Holaday, J.W. 1979. The opiate antagonist naloxone modifies the effects of electroconvulsive shock ( ECS) on blood pressure, heart rate and respiration. Brain Res. 177, 414–417.
Dworkin, B.R., Filewich, R.J., Miller, N.E., et al. 1979. Baroreceptor activation reduces reactivity to noxious stimulation: implications for hypertension. Science 205, 1299–1301.
Zamir, N. and Segal, M. 1979. Hypertension-induced analgesia: changes in pain sensitivity in experimental hypertensive rats. Brain Res. 160, 170–173.
Quock, R.M., Vaughn, L.K. and Kouchich, F.J. 1984. Influence of chronic naloxone treatment on development of hypertension in the spontaneously hypertensive rat. Naunyn-Schmied. Arch, Pharmacol. 325, 88–90.
Farsang, C and Kunos, G. 1979. Naloxone reverses the antihypertensive effects of clonidine. Br. J. Pharmacol. 67, 247–250.
Paterson, S.J., Robson, L.E. and Kosterlitz, H.W. 1983. Classification of opioid receptors. Br. Med. Bull 39, 31–36.
Schulz, R., Wuster, M. and Herz, A. 1981 Pharmacological characterization of the E-Opiate receptor. J. Pharmacol. Exp. Ther. 216, 604–606.
Schulz, R., Wuster, M., Kreuss, H., and Herz, A. 1980. Selective development of tolerance without dependence in multiple opiate receptors of mouse vas deferens. Nature 285, 242–243.
Vonvoigtlander, P.F., Lahti, R.A. and Ludeus, J.H. 1983. U-50,488: a selective and structurally novel non-mu (kappa) opioid agonist. Pharmacol. Exp. Ther. 224, 7.
Goldstein, A., James, I.F. Site-directed alkylation of multiple opioid receptors: II. pharmacologic selectivity. Molecular Pharm. In press.
Robson, L.E., Kosterlitz, H.W. U979. Specific protection of the binding sites of D-Ala2-D-Leu2-enkephalin (delta receptors) and dihydromorphine (mu-receptors). Proc. R. Soc. London, B 205, 425–432.
Bowen, W.D., Gentleman, S., Herkenhan, M. and Pert, C. 1981. Interconverting mu and delta forms of the opiate receptor in rat striatal patches. Proc. Nat’l Acad. Sci. 78, 4818–4822.
Lee, N.M., Smith, A.P. 1980. A protein-lipid model of the opiate receptor. Life Sci. 26, 1459–1464.
Rothman, R.B., and Westfall, T.C. 1982. Allosteric coupling between morphine and enkephalin receptors in vitro. Molecular Pharm. 21, 548–557.
Vaught, J.L., Rothman, R.B., and Westfall, R.C. 1982. Mu and delta receptors: their role in analgesia and in the differential effects of opioid peptides on analgesia. Life Sci. 30, 1443–1455.
Tortella, F.C. and Holaday, J.W. 1984. Mu and delta opioid receptor interactions in a rat model of drug induced seizures. Proc. West. Pharmacol. Soc. 27, 435–437.
Gillan, M.G.C., Kosterlitz, H.W., and Magnan, J. 1981. Unexpected antagonism in the rat vas deferens by benzo-morphans which are agonists in other pharmacological tests. Br. J. Pharmacol. 72, 13–15.
Ward, S.J., Portoghese, P.S., and Takemori, A.E. 1982. Pharmacological characterization in vivo of the novel opiate, p-funaltrexamine. J. Pharmacol. Exp. Ther. 220, 494.
Garzon, J., Jen, M.F., Sanchez-Blazquez, P., and Lee, N.M. 1982. Dynorphin (1–13), A long-lasting inhibitor of opiate receptor binding in vitro. Life Sci. 31, 1789.
Cowan, A., Geller, E.B., and Adler, M.W. 1979. Classification of opioids on the basis of change in seizure threshold in rat. Science 206, 456–467.
Tortella, F.C, Robles, L.E., Holaday, J.W. and Cowan, A. 1983. A selective role for mu-receptors in the regulation of opioid-induced changes in seizure threshold. Life Sci. 33, 603–606.
Tortella, F.C. and Holaday, J.W. 1984. Mu and delta opioid receptor interactions in a rat model of drug induced seizures. Proc. West. Pharmacol. Soc. 27, 435–437.
Holaday, J.W., Tseng, L.F., Loh, H.H. and Li, C.H. 1978. Thyrotropin releasing hormone antagonizes p-endorphin hypothermia and catalepsy. Life Sci. 23, 151–158.
Holaday, J.W., D’Amato, R.J. and Faden, A.I. 1981. Thyrotropin releasing hormone improves cardiovascular function in experimental endotoxic and hemorrhagic shock. Science 213, 216–218.
Holaday, J.W. and Bernton, E.W. 1984. Thyrotropin releasing hormone: a potent neuromodulator with therapeutic potential. Arch. Int. Med. 144, 1138–1140.
Holaday, J.W. and Faden, A.I. 1983. TRH: Autonomic effects upon cardiorespiratory function in endotoxic shock. Reg. Peptides 7, 111–125.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1986 Matinus Nijhoff Publishing, Boston
About this chapter
Cite this chapter
Holaday, J.W. (1986). Opioids and Other Neuropeptides: Functional Interactions with Autonomic Systems. In: Frederickson, R.C.A., Hendrie, H.C., Hingtgen, J.N., Aprison, M.H. (eds) Neuroregulation of Autonomic, Endocrine and Immune Systems. Topics in the Neurosciences, vol 2. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2315-0_8
Download citation
DOI: https://doi.org/10.1007/978-1-4613-2315-0_8
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-9424-5
Online ISBN: 978-1-4613-2315-0
eBook Packages: Springer Book Archive